- Home
- / Pasithea Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Pasithea Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.9
2024-10-29
Market Capitalization
$4.1 M
2024-10-29
Revenue
$486.6 K
FY, 2022
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 15.1K | 486.6K | |||
| Cost of goods sold | 17.3K | 113.2K | |||
| Gross profit | (2.2K) | 373.4K | |||
| Gross profit margin, % | 76.7% | ||||
| General and administrative expense | 4.5M | 12.5M | 7.9M | 7.1M | |
| Operating expense total | 4.5M | 15.2M | 16.0M | 14.2M | |
| EBIT | (4.5M) | (14.8M) | (16.0M) | (14.2M) | |
| EBIT margin, % | -3045.1% | ||||
| Investment income | 415.4K | 423.2K | |||
| Interest income | 415.4K | 423.2K | |||
| Interest expense | (508.0) | ||||
| Pre tax profit | (2.2M) | (13.9M) | (15.5M) | (13.9M) | (20.4M) |
| Net Income | (2.2M) | (13.9M) | (16.0M) | (13.9M) | |
| EPS | (0.5) | (0.4) | (2.9) |